Notification [x]
My IM Status
Clinical Trials


Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine

Fallopian Tube Cancer Clinical Trials


A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Phoenix : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Tucson : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Phoenix : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Scottsdale :

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Tucson : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Tucson : University of Arizona Cancer Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

California

Los Angeles : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Los Angeles : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Stanford : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Fullerton : Saint Jude Heritage Medical Center

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Fullerton : Saint Jude Heritage Medical Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Los Angeles : University of California Los Angeles

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Francisco : UCSF

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Francisco : University of California San Francisco (UCSF)

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Francisco : University of California, San Francisco

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Luis Obispo : Coastal Integrative Cancer Care

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Luis Obispo : Coastal Integrative Cancer Care

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Santa Maria : Central Coast Medical Oncology

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Santa Maria : Central Coast Medical Oncology

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Santa Monica : University of California Los Angeles (UCLA)

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Stanford : Stanford University

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Colorado

Lakewood : Rocky Mountain Cancer Centers

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Lakewood : Rocky Mountain Cancer Centers

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Florida

Sarasota : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Tampa : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Hollywood : Memorial Healthcare System

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Jacksonville : Mayo Clinic Jacksonville

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Orlando : Florida Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sarasota : Sarah Cannon Research Institute

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sarasota : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Tampa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Georgia

Atlanta : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Savannah : Memorial University Medical Center

GOG 0273: Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Illinois

Chicago : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Indiana

Indianapolis : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Indianapolis : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Lafayette :

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Lafayette : Horizon BioAdvance

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Maryland

Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Baltimore : Johns Hopkins Universty

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Baltimore : Johns Hopkins Kimmel Cancer Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Massachusetts

Boston : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Boston : Dana-Farber Cancer Institute

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Boston : Dana-Farber Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Carcinoma

Boston : Massachusetts General Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Boston : Massachusetts General Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Boston : Dana-Farber Cancer Institute

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Michigan

Detroit : Karmanos Cancer Institute

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Detroit : Karmanos Cancer Institute - Wayne State University

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Minnesota

Minneapolis : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Rochester : Mayo Clinic Updated

Patients are needed to participate in a clinical research study of Alvimopan and Placebo to evaluate Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Missouri

St. Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

St. Louis : Washington University School of Medicine - Division of Gynaecological Oncology

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

St. Louis : Washington University School of Medicine

Study Of Intraperitoneal EGEN-001 Administered In Combination With Pegylated Liposomal-Doxorubicin In Patients With Recurrent Or Persistent Epithelial Ovarian, Fallopian Tube Or Peritoneal Cancer

Nevada

Henderson : Comprehensive Cancer Centers of Nevada

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

New Jersey

Morristown : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Basking Ridge : Memorial Sloan Kettering Cancer Center at Basking Ridge Updated

Patients are needed to participate in a clinical research study of Paclitaxel, Bevacizumab, Cisplatin and Olaparib to evaluate Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

New Brunswick : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

New Mexico

Farmington : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

New York

New York : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

New York : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Commack : Memorial Sloan Kettering Cancer Center @ Suffolk Updated

Patients are needed to participate in a clinical research study of Paclitaxel, Bevacizumab, Cisplatin and Olaparib to evaluate Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

New York : Memorial Sloan Kettering Cancer Center Updated

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

New York : Memorial Sloan-Kettering Cancer Center

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

New York : Columbia University Medical Center

Patients are needed to participate in a clinical research study of Carboplatin, paclitaxel, and bevacizumab to evaluate Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

New York :

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

New York : Memorial Sloan-Kettering Cancer Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

New York : New York University Langone Medical Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

New York : Memorial Sloan Kettering Cancer Center Updated

Patients are needed to participate in a clinical research study of Paclitaxel, Bevacizumab, Cisplatin and Olaparib to evaluate Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

Rockville Centre : Memorial Sloan Kettering Cancer Center at Mercy Medical Center Updated

Patients are needed to participate in a clinical research study of Paclitaxel, Bevacizumab, Cisplatin and Olaparib to evaluate Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

Sleepy Hollow : Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Updated

Patients are needed to participate in a clinical research study of Paclitaxel, Bevacizumab, Cisplatin and Olaparib to evaluate Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

North Carolina

Durham : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Winston-Salem : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Asheville : Hope Women's Cancer Centers

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Asheville : Hope - A Woman's Cancer Institute

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Durham : Duke Cancer Institute

Patients are needed to participate in a clinical research study evaluating BIBF 1120 for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Ohio

Toledo : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Columbus : The Ohio State University Wexner Medical Center

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Columbus : The Ohio State University Wexner Medical Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Oklahoma

Oklahoma City : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Oklahoma City :

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Oklahoma City : University of Oklahoma

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Oklahoma City : University of Oklahoma Health Sciences Center

Study Of Intraperitoneal EGEN-001 Administered In Combination With Pegylated Liposomal-Doxorubicin In Patients With Recurrent Or Persistent Epithelial Ovarian, Fallopian Tube Or Peritoneal Cancer

Pennsylvania

Abington : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Philadelphia : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Philadelphia : University of Pennsylvania

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Philadelphia : University of Pennsylvania

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Philadelphia : Fox Chase Cancer Center

Patients are needed to participate in a clinical research study of Carboplatin, paclitaxel, and bevacizumab to evaluate Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

Philadelphia : Fox Chase Cancer Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Pittsburgh : Magee-Womens Hospital of UPMC

A clinical trial to evaluate treatments using intravenous docetaxel with intraperitoneal oxaliplatin and intravenous oxaliplatin with intraperitoneal docetaxel for patients with Ovarian Cancer, Peritoneal Cancer or Fallopian Tube Cancer

Pittsburgh : Magee-Womens Hospital of UPMC

A Phase 2 clinical study for patients with Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Rhode Island

Providence : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Tennessee

Nashville : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Nashville : Sarah Cannon Research Institute

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Nashville : Sarah Cannon Research Institute Updated

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Texas

Austin : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Dallas : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Fort Worth : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

San Antonio : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Woodlands : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Bedford : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Fort Worth : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Houston : UTMD Anderson Cancer Clinical Lab

A Phase 1/Phase 2 clinical study for patients with Primary Peritoneal Carcinoma

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Houston : The University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Antonio : South Texas Accelerated Research Therapeutics Updated

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

The Woodlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Tyler : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Virginia

Charlottesville : University of Virginia

A clinical research study of Gemcitabine and pazopanib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Charlottesville : University of Virginia

Patients are needed to participate in a clinical research study evaluating BIBF 1120 for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Charlottesville : University of Virginia

Patients are needed to participate in a clinical research study of Carboplatin, paclitaxel, and bevacizumab to evaluate Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer

Norfolk : Virginia Oncology Associates

Patients are needed to participate in a clinical research study evaluating BIBF 1120 for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Washington

Vancouver : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Seattle : University of Washington at Seattle

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Seattle : University of Washington - Seattle Cancer Care Alliance

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Australia

Adelaide : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Bedford Park : Flinders Medical Centre

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Bedfork Park : Flinders Cancer Clinic - Flinders Medical Centre (FMC)

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Greenslopes : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Herston : Royal Brisbane & Women's Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Herston : Royal Brisbane & Women's Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Nedlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Nedlands : Sir Charles Gairdner Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Nedlands : Charles Gairdner Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Parkville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Parkville : Royal Melbourne Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Parkville : Royal Melbourne Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Subiaco : St John of God Hospital Subiaco

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sydney : Prince of Wales Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sydney : Prince of Wales Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Westmead : Westmead Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Westmead : Crown Princess Mary Cancer Centre

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Austria

Graz : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Innsbruck : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Belgium

Antwerpen : AZ St Augustinus

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Leuven : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Leuven : UZ Leuven

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Liège : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Namur : Clinique Sainte-Elisabeth

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Canada

Calgary : Tom Baker Cancer Centre

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Calgary : Tom Baker Cancer Centre

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Edmonton : Cross Cancer Institute

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Edmonton : Cross Cancer Centre

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Hamilton : Juravinski Cancer Centre

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : London Regional Cancer Centre

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : London Regional Cancer Centre

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Montreal : Centre Hospitalier de L'Universite de Montreal

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Ottawa : Ottawa Hospital Cancer Centre

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Ottawa : Ottawa Hospital Cancer Centre

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Quebec : CHU de Québec L'Hôtel-Dieu de Québec

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Toronto : Princess Margaret Cancer Centre

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Toronto : Princess Margaret Cancer Centre

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Vancouver : Vancouver Cancer Centre, British Columbia Cancer Agency (BCCA)

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Denmark

Aalborg : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Copenhagen : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Herlev : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Odense : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

France

Lille : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Montpellier : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Nice : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Saint Brieuc : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

St. Herblain Cedex : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Strasbourg : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Bordeaux : Institute Bergonie

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Bordeaux : Institut Bergonie

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Caen Cedex 05 : Centre Francois Baclesse

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Lyon : Centre Leon Berard

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Lyon : Centre Leon Berard

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Nantes : Centre Catherine de Sienne

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Nantes Cedex : Centre Catherine de Sienne

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Paris : Hospital Tenon

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Paris : Hopital Hotel-Dieu

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Paris : Hopital Hotel-Dieu

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Paris : Hopital Tenon

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Pierre Benite : Centre Hospitalier Lyon Sud

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Pierre-Benite : Centre Hospitalier Lyon Sud

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Toulouse : Institut Claudius Regaud

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Toulouse : Institut Claudius Regaud

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Villejuif : Institut Gustave Roussy

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Villejuif : Institut de cancerologie Gustave Roussy

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Germany

Berlin : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Düsseldorf : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Hamburg : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Hannover : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Nordrhein-Westfalen : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Aalen : Ostalbklinikum

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Berlin : Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik für Frauenheilkunde

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Berlin : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Chemnitz : Klinikum Chemnitz gGmbH

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Dresden : Technische Universität Dresden

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Erlangen : Univerisity Hospital; Dept. of Gynecology & Obstetrics

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Essen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Essen : University hospital, Dept. of gynecology & obstetrics

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Esslingen : Klinikum Esslingen

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Frankfurt am Main : Klinikum der Johann Wolfgang-Goethe-Universität

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Frankfurt am Main : Klinikum der JWG Universität Frankfurt

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Freiburg : Universitätsklinikum Freiburg, Frauenklinik

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Greifswald : Gynecologic Clinic of the Ernst-Moritz-Arndt-University

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Hannover : Medizinische Hochschule

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Kiel : Universitätsklinikum Schleswig-Holstein Campus Kiel, Klinik f. Gynäkologie u. Geburtshilfe

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Ludwigsburg : Klinikum Ludwigsburg-Bietigheim gGmbH

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Mainz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Marburg : Klinikum der Philipps-Universität Marburg, Klinik für Gynäkologie, Gynäkologische Endokrinologie

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Munich : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Munich : Rotkreuzklinikum Muenchen gGmbH

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Munich : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Munich : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Offenburg : St. Josefsklinik

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Paderborn : St. Vincenz-Krankenhaus

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Regensburg : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Rostock : Klinikum Südstadt

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Stuttgart : Klinikum Stuttgart

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Stuttgart : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Ulm : Universitätsklinikum, Universitätsfrauenklinik

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Wiesbaden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Wiesbaden : Dr. Horst Schmidt Klinik, Klinik fuer Gynaekologie und Gyn. Onkologie

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Wiesbaden : HSK, Dr. Horst Schmidt Klinik GmbH

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Wolfsburg : Klinikum der Stadt Wolfsburg

Patients are needed to participate in a clinical research study evaluating Tumor Debulking Surgery (surgery in recurrent ovarian disease) for the treatment of Fallopian Tube Cancer, Ovarian Cancer or Peritoneal Cavity Cancer

Hungary

Budapest : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Miskolc : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Budapest : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Debrecen : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Szeged : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Israel

Haifa : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Jerusalem : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Tel Aviv : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Haifa : Rambam Health Care Campus

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Ramat Gan : Sheba Medical Center

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Ramat Gan : Oncology Institute, Sheba Medical Center

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Tel Aviv : Tel Aviv Sourasky Medical Center

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Zerifin : Assaf Harofeh M.C.

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Italy

Bologna : Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Faenza : Oncology Unit City Hospital degli Infermi

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Meldola : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Milan : Fondazione IRCCS National Cancer Institute

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Milan : Instituto Europeo di Oncologia

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Milan : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Milan : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Modena : Azienda Ospedaliero Universitaria Policlinico di Modena

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Oviedo : Hospital Central de Asturias

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Reggio Emilia : Arcispedale Santa Maria Nuova IRCCS

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Roma : Policlinico Universitario Agostino Gemelli

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Rome : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

New Zealand

Auckland : Auckland City Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Newtown : Wellington Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Palmerston North : Palmsteron North Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Norway

Bergen : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Oslo : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Poland

Bialystok : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Gdansk : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Bydgoszcz : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Gdansk : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Lublin : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Olsztyn : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Poznan : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Rzeszow : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Romania

Brasov : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Bucharest : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Cluj-Napoca : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Cluj-Napoca : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Craiova : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Oradea : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Timisoara : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Timisoara : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Russian Federation

Kazan : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Moscow : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Moscow : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Pyatigorsk : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

St Petersburg : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

St. Petersburg : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

St. Petersburg : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Volgograd : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Yaroslavl : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Spain

Asturias : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Barcelona : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Madrid : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Palma de Mallorca : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

A Coruna : Centro Oncologico de Galica

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Barcelona : Hospital Vall d'Hebron

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Barcelona : Hospital Vall D'Hebron

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Barcelona : Hospital Vall d'Hebron

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Barcelona : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Madrid : Hospital Universitario San Carlos

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Madrid : Centro Integral Oncológico Clara Campal, Hospital de Madrid Norte-San Chinarro

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Madrid : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Madrid : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Madrid : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Sevilla : Hospital Universitario Virgen del Rocío

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Valencia : Instituto Valencia de Oncologia-Fundacion

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Valencia : Hospital Clinico Universitario de Valencia

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Valencia : Hospital Clinico Universitario de Valencia

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Valencia : Instituto Valencia de Oncologia

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Valencia : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Sweden

Lund : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Östergötlands län : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Stockholm : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

United Kingdom

Bangor : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Kent : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

London : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

London : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Nottingham : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Somerset : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Wirral : Research Site

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Bebington : The Clatterbridge Cancer Centre NHS Foundation Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Cambridge : Royal Marsden NHS Foundation Trust

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Cambridge : Addenbrooke's Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Glasgow : Beatson West of Scotland Cancer Centre

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Glasgow : Beatson West of Scotland Cancer Centre

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Greater London : Mount Vernon Hospital

A Phase 2 clinical study for patients with Ovarian Cancer or Fallopian Tube Cancer

Guildford : Royal Surrey County Hospital NHS Foundation Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Leeds : Leeds Teaching Hospitals NHS Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Leeds : St. James University Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Leeds : St James University Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : Sarah Cannon Research Institute UK

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : Guy's and St Thomas NHS Foundation Trust

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : University College London Cancer Institute

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : Royal Marsden Hospital

A Phase 2 clinical study for patients with Ovarian Cancer or Fallopian Tube Cancer

London : Royal Marsden Hospital

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : Barts Health NHS Trust

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : Imperial College Healthcare NHS Trust

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : University College London

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : Sarah Cannon Reserach Institute UK

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : University College London

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : Imperial College Healthcare NHS Trust - Hammersmith Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

London : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

London : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Manchester : The Christie NHS Foundation Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Manchester : The Christie NHS Foundation Trust

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Manchester : The Christie NHS Foundation Trust

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Newcastle Upon Tyne : Newcastle University

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Newcastle Upon Tyne : Sir Bobby Robson Cancer trials research Centre, Northern Centre For Cancer Care

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Newcastle upon Tyne : Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Oxford : Oxford University Hospitals NHS Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Plymouth : Plymouth Hospitals NHS Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Slough : Wexham Park Hospital

A Phase 2 clinical study for patients with Ovarian Cancer or Fallopian Tube Cancer

Sutton : Royal Marsden Sutton Hospital

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sutton : Investigator

Patients are needed to participate in a clinical research study of PankoMab-GEX and Placebo to evaluate Epithelial Ovarian Cancer

Quick Search
Powered by DZOIC Handshakes Professional